Losartan Induced Angioedema, a Rare Case Report and the Dilemma of Using Angiotensin II Receptor Blockers in Patients with Previous Angioedema with Angiotensin Converting Enzyme Inhibitors
Angiotensin Receptor Blockers (ARB) are used as an alternative of Angiotensin Converting Enzyme Inhibitors (ACEI) in patients where ACEIs cannot be used because of their known adverse effects, cough and angioedema. Thus ARB induced angioedema is considered to be a rare phenomenon and it is continued to be used as an alternatives of ACEIs. In this case report, we reported a case of 78-year-old gentleman who presented to emergency department with losartan, an ARB induced angioedema, who did not have history of any previous use of ACEIs. He was given steroids and antihistamine as a treatment. His angioedema resolved rapidly and he was discharged after six hours of emergency department (ED) observation with stable hemodynamically. We, the authors by reporting this case, wants to make clinicians aware ARB, however rarely, can cause angioedema, which can be life threatening if clinicians are not aware of it and diagnose and stop the offending drug promptly and treat it early.
References
[1]
Remuzzi, G. and Ruggenenti, P. (2006) Overview of Randomised Trials of ACE Inhibitors. The Lancet, 368, 555-556. https://doi.org/10.1016/s0140-6736(06)69172-1
[2]
Goodfriend, T.L., Elliott, M.E. and Catt, K.J. (1996) Angiotensin Receptors and Their Antagonists. New England Journal of Medicine, 334, 1649-1655. https://doi.org/10.1056/nejm199606203342507
[3]
Cha, Y.J. and Pearson, V.E. (1999) Angioedema Due to Losartan. Annals of Pharmacotherapy, 33, 936-938. https://doi.org/10.1345/aph.18396
[4]
Cicardi, M., Aberer, W., Banerji, A., Bas, M., Bernstein, J.A., Bork, K., et al. (2014) Classification, Diagnosis, and Approach to Treatment for Angioedema: Consensus Report from the Hereditary Angioedema International Working Group. Allergy, 69, 602-616. https://doi.org/10.1111/all.12380
[5]
Zingale, L.C., Beltrami, L., Zanichelli, A., Maggioni, L., Pappalardo, E., Cicardi, B., et al. (2006) Angioedema without Urticaria: A Large Clinical Survey. Canadian Medical Association Journal, 175, 1065-1070. https://doi.org/10.1503/cmaj.060535
[6]
Jacques, P., Lavoie, A., Bedard, P., Brunet, C. and Hebert, J. (1992) Chronic Idiopathic Urticaria: Profiles of Skin Mast Cell Histamine Release during Active Disease and Remission. Journal of Allergy and Clinical Immunology, 89, 1139-1143. https://doi.org/10.1016/0091-6749(92)90297-f
[7]
Busse, P.J. and Christiansen, S.C. (2020) Hereditary Angioedema. New England Journal of Medicine, 382, 1136-1148. https://doi.org/10.1056/nejmra1808012
[8]
Kostis, W.J., Shetty, M., Chowdhury, Y.S. and Kostis, J.B. (2018) ACE Inhibitor-Induced Angioedema: A Review. Current Hypertension Reports, 20, Article No. 55. https://doi.org/10.1007/s11906-018-0859-x
[9]
Irons, B.K. and Kumar, A. (2003) Valsartan-Induced Angioedema. Annals of Pharmacotherapy, 37, 1024-1027. https://doi.org/10.1345/aph.1c520
[10]
Longhurst, H.J. and Bork, K. (2019) Hereditary Angioedema: An Update on Causes, Manifestations and Treatment. British Journal of Hospital Medicine, 80, 391-398. https://doi.org/10.12968/hmed.2019.80.7.391
[11]
Diestro, J.D.B., Sedano, L.S.P., Reyes, N.G.D. and San Jose, M.C.Z. (2019) Hemilingual Angioedema after Thrombolysis in a Patient on an Angiotensin II Receptor Blocker. Journal of Stroke and Cerebrovascular Diseases, 28, e44-e45. https://doi.org/10.1016/j.jstrokecerebrovasdis.2019.01.030
[12]
Shino, M., Takahashi, K., Murata, T., Iida, H., Yasuoka, Y. and Furuya, N. (2011) Angiotensin II Receptor Blocker-Induced Angioedema in the Oral Floor and Epiglottis. American Journal of Otolaryngology, 32, 624-626. https://doi.org/10.1016/j.amjoto.2010.11.014
[13]
Alhowary, A., Odat, H., Alali, O. and Al-Omari, A. (2018) Intraoperative Angioedema Induced by Angiotensin II Receptor Blocker: A Case Report. Patient Safety in Surgery, 12, Article No. 27. https://doi.org/10.1186/s13037-018-0174-0
[14]
Chiu, A.G., Krowiak, E.J. and Deeb, Z.E. (2001) Angioedema Associated with Angiotensin II Receptor Antagonists: Challenging Our Knowledge of Angioedema and Its Etiology. The Laryngoscope, 111, 1729-1731. https://doi.org/10.1097/00005537-200110000-00011
[15]
Al-Khudari, S., Loochtan, M.J., Peterson, E. and Yaremchuk, K.L. (2011) Management of Angiotensin-Converting Enzyme Inhibitor-induced Angioedema. The Laryngoscope, 121, 2327-2334. https://doi.org/10.1002/lary.22349
[16]
Lehmann, A. (2008) Ecallantide (DX-88), a Plasma Kallikrein Inhibitor for the Treatment of Hereditary Angioedema and the Prevention of Blood Loss in On-Pump Cardiothoracic Surgery. Expert Opinion on Biological Therapy, 8, 1187-1199. https://doi.org/10.1517/14712598.8.8.1187
